3-(4-Bromophenyl)isoxazol-5(2H)-one

Catalog No.: 
ACSTJF046
CAS No.: 
1195674-03-3
Molecular Formula: 
C9H6BrNO2
Molecular Weight: 
240.06
3-(4-Bromophenyl)isoxazol-5(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$106.00In stockInquiry
250mg95%$185.00In stockInquiry
1g95%$501.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-Bromophenyl)isoxazol-5(2H)-one
IUPAC Name3-(4-bromophenyl)isoxazol-5(2H)-one
Molecular FormulaC9H6BrNO2
Molecular Weight240.06
SMILESO=C1C=C(C2=CC=C(Br)C=C2)NO1
InChI KeySJZVBCDBPNOPHV-UHFFFAOYSA-N
Synonym5(2H)-Isoxazolone, 3-(4-bromophenyl)-;3-(4-Bromophenyl)isoxazol-5(2H)-one
CAS No.1195674-03-3
PubChem CID75359333

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACSTJF046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEGJX062 route compound structure diagram
    ACEGJX0625467-74-3In Stock
  4. Then
  5. ACSTJF046 route product structure diagram
    ACSTJF0461195674-03-3In Stock
Inquiry

2. ACSTJF046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEGJX062 route compound structure diagram
    ACEGJX0625467-74-3In Stock
  4. Then
  5. ACSTJF046 route product structure diagram
    ACSTJF0461195674-03-3In Stock
Inquiry

3. ACSTJF046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSTJF046 route product structure diagram
    ACSTJF0461195674-03-3In Stock
Inquiry

Comments (0)